Literature DB >> 1779617

Fifteen years' experience with 212 hyperammonaemic cases at a metabolic unit.

A Tokatli1, T Coşkun, I Ozalp.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1779617     DOI： 10.1007/bf01799938

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  7 in total

1.  Consanguinity in Turkey in 1988.

Authors:  E Tuncbilek; M Ulusoy
Journal:  Nufusbil Derg       Date:  1989

2.  Aspirin as a risk factor in Reye's syndrome.

Authors:  R J Waldman; W N Hall; H McGee; G Van Amburg
Journal:  JAMA       Date:  1982-06-11       Impact factor: 56.272

3.  Neonatal hyperammonemic coma.

Authors:  S W Brusilow; M L Batshaw; L Waber
Journal:  Adv Pediatr       Date:  1982

4.  Inborn errors of metabolism in children referred with Reye's syndrome. A changing pattern.

Authors:  P C Rowe; D Valle; S W Brusilow
Journal:  JAMA       Date:  1988-12-02       Impact factor: 56.272

5.  Hyperammonemia.

Authors:  M L Batshaw
Journal:  Curr Probl Pediatr       Date:  1984-11

6.  Valproate-induced hyperammonemia.

Authors:  M L Batshaw; S W Brusilow
Journal:  Ann Neurol       Date:  1982-03       Impact factor: 10.422

7.  Familial cirrhosis.

Authors:  N Koçak; S Ozsoylu
Journal:  Am J Dis Child       Date:  1979-11
  7 in total
  3 in total

1.  Hyperammonemic encephalopathy caused by carnitine deficiency.

Authors:  Berkeley N Limketkai; Stephen D Zucker
Journal:  J Gen Intern Med       Date:  2007-12-13       Impact factor: 5.128

2.  Clinical Relevance and Cost-Savings of Levocarnitine Versus Ammonul in the Management Of Hyperammonemia in a Cancer Patient: The Impact of a Clinical Pharmacist.

Authors:  Chukwuma Anyanwu; Chinonso Ezeudu; Hoa Le; Oliver Egwim
Journal:  P T       Date:  2018-01

3.  Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.

Authors:  Yudai Koya; Michihiko Shibata; Michio Senju; Yuichi Honma; Masaaki Hiura; Masahiro Ishii; Shirou Matsumoto; Masaru Harada
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.